Search Results

Junying Yuan: changing avenues without losing focus. Interview by Nicole LeBrasseur.

• Authors : Yuan J

Subjects: Apoptosis*; Animals ; Awards and Prizes Yuan J

• Source: The Journal of cell biology [J Cell Biol] 2007 Oct 22; Vol. 179 (2), pp. 174-5.Publisher: Rockefeller University Press Country of Publication: United States NLM ID: 0375356 Publication Model: Print Cited Medium: Print ISSN:

Record details

Dana-Farber Cancer Institute Researchers Discuss Research in Squamous Cell Carcinoma (Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders).

• Source: Immunotherapy Weekly. 2024, pages. 1243

Record details

Patent Issued for Selective targeting of apoptosis proteins by structurally-stabilized and/or cysteine-reactive NOXA peptides (USPTO 11834520).

• Source: Medical Patent Business Week. 2023, pages. 6881

Record details

Findings on Aneuploidy Discussed by Investigators at Dana-Farber Cancer Institute (Impact of Aneuploidy and Chromosome 9p Loss On Tumor Immune Microenvironment and Immune Checkpoint Inhibitor Efficacy In Nsclc).

• Source: Immunotherapy Weekly. 2023, pages. 2239

Record details

Reports from Dana-Farber Cancer Institute Advance Knowledge in Carcinomas (Novel Immune Therapies for Renal Cell Carcinoma Looking Beyond the Programmed Cell Death Protein 1 and Cytotoxic T-lymphocyte-associated Protein 4 Axes).

• Source: Immunotherapy Weekly. 2023, pages. 4682

Record details

New Life Science Data Have Been Reported by Researchers at Harvard Medical School (The Prophylactic Value of Tnf-α Inhibitors Against Retinal Cell Apoptosis and Optic Nerve Axon Loss After Corneal Surgery or Trauma).

• Source: Health & Medicine Week. 2023, pages. 3890

Record details

Clinical Analysis.

• Authors : Bednar, Joseph

Subjects: *APOPTOSIS; *BUSINESS partnerships; *MEDICAL centersMASSACHUSETTSSCHWARTZ, Lawrence

• Source: BusinessWest. 11/13/2006, Vol. 23 Issue 15, p14-55. 3p.

Record details

Data on Head and Neck Cancer Reported by Researchers at Dana-Farber Cancer Institute (Preexisting Tumor-resident T Cells With Cytotoxic Potential Associate With Response To Neoadjuvant Anti-pd-1 In Head and Neck Cancer).

• Source: Immunotherapy Weekly. 2023, pages. 630

Record details

Protocatechuic acid and quercetin attenuate ETEC-caused IPEC-1 cell inflammation and injury associated with inhibition of necroptosis and pyroptosis signaling pathways.

• Authors : Xiao, Kan; Zhou, Mohan; Lv, Qingqing

• Source: Journal of Animal Science and Biotechnology. February 1, 2023, Vol. 14 Issue 1.

Record details

New Findings in Ovarian Cancer Described from Dana-Farber Cancer Institute (Enhanced Efficacy of Simultaneous Pd-1 and Pd-l1 Immune Checkpoint Blockade In High-grade Serous Ovarian Cancer).

• Source: Women's Health Weekly. 2021, pages. 292

Record details